In case you missed it: Dec. 14 to Dec. 18


It was a very busy week for the Contemporary OB/GYN® team.

This week’s top articles included:

State of the Industry 2020

COVID-19, racial and gender equality, the rising role of telehealth - many factors converged to make 2020 a year we won’t soon forget. Here is where the industry stands.

Transvaginal ultrasound therapy for symptomatic uterine leiomyomas

A small clinical trial has found that transvaginal high-intensity focused ultrasound (vHIFU) is a promising treatment for women with symptomatic uterine leiomyomas.

Pfizer-BioNTech COVID-19 vaccine authorized for emergency use

U.S. FDA staff have recommended monitoring individuals who get the Pfizer or Moderna vaccine shots for possible cases of Bell’s palsy.

S2E9: Linda Fan, MD, on telehealth in the second stage of COVID-19

This episode of Pap Talk features Linda Fan, MD, an assistant professor of Obstetrics, Gynecology, and Reproductive Sciences; Section Chief of Gynecology; and director of Gynecologic Quality and Safety at the Yale School of Medicine.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.